Opendata, web and dolomites

INSPIRE SIGNED

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INSPIRE project word cloud

Explore the words cloud of the INSPIRE project. It provides you a very rough idea of what is the project "INSPIRE" about.

pharmacodynamic    technological    safety    ing    toxicity    vivo    platform    understand    solutions    academic    3rs    esrs    providers    pharmacology    changing    wp3    functional    adverse    limitation    unparalleled    detect    cv    industry    prevalent    drug    cardiovascular    15    predictions    preclinical    delivering    cardio    vi    scientists    candidates    onset    animals    transferable    regulators    events    structural    courses    intersectoral    equip    teams    imaging    validated    inspire    hands    local    new    hence    hardware    exploration    stage    off    thereby    software    generation    wp1    assays    screening    secondments    oncology    wp4    collaborations    sp    combination    toxicities    feedback    companies    innovative    unites    additionally    indicates    training    exposure    dynamic    cardiomyocytes    attrition    hospitals    mass    mechanisms    humanized    adapt    screens    network    spectroscopy    multidisciplinary    laboratory    expertise    fail    scientific    reduce    wp2    vision    integration    balanced    constitutes    pharmaceutical    vitro    silico    representing    skills    uses    undesirable    create    clinical    exploring    haemodynamics   

Project "INSPIRE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT ANTWERPEN 

Organization address
address: PRINSSTRAAT 13
city: ANTWERPEN
postcode: 2000
website: www.ua.ac.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 4˙021˙968 €
 EC max contribution 4˙021˙968 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT ANTWERPEN BE (ANTWERPEN) coordinator 768˙960.00
2    THE UNIVERSITY OF NOTTINGHAM UK (NOTTINGHAM) participant 606˙345.00
3    NOTOCORD SYSTEMS FR (LE PECQ) participant 549˙604.00
4    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 531˙239.00
5    INSTITUT NATIONAL DE RECHERCHE ENINFORMATIQUE ET AUTOMATIQUE FR (LE CHESNAY CEDEX) participant 274˙802.00
6    NCARDIA BV NL (LEIDEN) participant 265˙619.00
7    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 263˙500.00
8    UCB BIOPHARMA SRL BE (BRUXELLES) participant 256˙320.00
9    BOEHRINGER INGELHEIM PHARMA GMBH &CO KG DE (INGELHEIM) participant 252˙788.00
10    TSE SYSTEMS GMBH DE (BAD HOMBURG VOR DER HOHE) participant 252˙788.00

Map

 Project objective

New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety Pharmacology (SP) aims to detect, understand and reduce undesirable pharmacodynamic effects early-on. Especially, cardiovascular (CV) toxicity is problematic, as it is the most prevalent reason for failure during preclinical development. Moreover, CV toxicity remains a key reason for drug attrition during clinical development and beyond. This indicates current SP screens fail to detect a number of (late-onset) functional or structural CV toxicities. Additionally, SP uses a significant number of laboratory animals, thereby creating opportunities for a better implementation of the 3Rs. The vision of INSPIRE is to advance and “inspire” SP by exploring new technological capabilities (WP1), addressing emerging CV concerns (WP2) and delivering new validated solutions for CV safety screening (WP3). To this end, INSPIRE unites expertise from academic teams, technology-providers, pharmaceutical companies, regulators and hospitals to create a European training platform for 15 Early Stage Researchers (ESRs). Key innovative aspects of INSPIRE include: i) in vitro humanized cardiomyocytes assays, ii) unparalleled in vivo hardware/software solutions, iii) in silico predictions of haemodynamics, iv) mass spectroscopy imaging of drug exposure, v) exploration of mechanisms of late-onset CV toxicity, as observed in cardio-oncology, and vi) early integration of feedback from industry and regulators. Overall, INSPIRE constitutes a multidisciplinary and intersectoral training programme (WP4) with a balanced combination of hands-on research training, intersectoral secondments, local courses and network-wide events on scientific and transferable skills, enabling future R&I collaborations. Hence, INSPIRE will equip the future generation of SP scientists with a wide range of scientific knowledge and the ability to adapt to a dynamic ever-changing industry.

 Deliverables

List of deliverables.
Start recruitment procedure Other 2020-02-27 15:24:01

Take a look to the deliverables list in detail:  detailed list of INSPIRE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INSPIRE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INSPIRE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

EAGRE (2020)

Eagre/Aegir: high-seas wave-impact modelling

Read More  

TECHNOTRAIN (2018)

Enabling TECHNOlogies-driven chemistry: a tailored TRAINing research program for batch and flow synthesis of chiral amino derivatives

Read More  

ApPEARS (2019)

Appearance Printing - European Advanced Research School

Read More